RT Journal Article
SR Electronic
T1 PERSONAL PROTECTIVE EQUIPMENT (PPE) USING IN ANTALYA 112 EMERGENCY AMBULANCE SERVICES DURING OUTBREAK
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.16.20129171
DO 10.1101/2020.06.16.20129171
A1 Mehmet Fatih Gulsen
A1 Münevver Kurt
A1 Isil Kaleli
A1 Ayhan Ulasti
YR 2020
UL http://medrxiv.org/content/early/2020/06/19/2020.06.16.20129171.abstract
AB A new type of Coronavirus (SARS-CoV-2) which was identified on January 7th, 2020; which caused disease named COVID-19 caused by this virus. The first confirmed COVID-19 (+) case in Turkey was detected on March 11th, 2020. The first COVID-19 case in Antalya was detected on March 14th, 2020 and transferred by an Antalya 112 emergency ambulance to hospital.The aim of this descriptive, retrospective and cross-sectional study which is conducted between the dates of March 14th, 2020 – May 31st, 2020, is to evaluate the level of Personal Protective Equipment (PPE) usage, the risk analysis results and follow-up measures of Antalya 112 ambulance teams during COVID-19 outbreak. There were 5344 possible and 787 confirmed COVID-19 (+) positive ambulance cases between the dates of study conducted. The majority of these cases were male (62%) and over the age of 65 (47%). The majority of cases were result in “transferred to healthcare facilities” (75.48%). The total 2361 ambulance team workers were taken to risk analysis measurements and then followed-up procedures. The majority of ambulance team members were assessed with no risk available. The Level-4 PPE (N95/FPP-Goggle/face protection-Gloves-Apron/coverall) were used most commonly (84.50%). The HCWs who use Level-4 PPE for confirmed COVID-19 (+) cases, were assessed no risk exposed. The using mask on patient and the level of PPE usage showed negative correlation with risk level of HCWs.There are only 2 HCWs diagnosed with COVID-19 by CT scan. The follow-up procedures of two HCWs has been finalized, and both of them cured, follow-ups ended. The studies about easy-to-use, high-tech PPE with maximum protection, are recommended for further investigations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding statementAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Directorate of Antalya Provincial Health Ethical Committee of Antalya Training & Research HospitalAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesIn this study, data (COVID-19 confirmed case information, level of PPE usage of ambulance teams, and risk analysis results of follow-up measures of HCWs) were obtained from Directorate of Antalya Emergency Ambulance Services. The level of risk analysis results, follow-up measures of HCWs are obtain by the COVID-19 response team and ASOS records (Emergency Health Information Systems).